Skip to content
Home/Companies/Healthcare/Synthpop
Synthpop

Synthpop

Healthcare·US·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Synthpop?

Synthpop is currently owned by Newfund Management through Newfund HEKA (2023 vintage), since 2023.

Hand-verified · updated 2026-05-07

Newfund Management
Investor
Newfund Management
Newfund HEKA · 2023 · VC

Key facts

HQUS
SectorHealthcare
StatusActive
Websitewww.synthpop.ai

More from Newfund HEKA

Other portfolio companies in the same fund.

AI Stroke
Active
HealthcareFrance· 2025
Diagnoly
Active
HealthTechFrance· 2025
DUX Healthcare
Active
HealthcareUS· 2025
Moovd
Active
HealthcareNetherlands· 2025
Olimpe Technlogy
Active
HealthcareFrance· 2025
One Zyme
Active
HealthcareUS· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Synthpop

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Synthpop?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Synthpop.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue